Business
Medical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise
Medical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise\nPR Newswire\nSAN DIEGO, Feb. 11, 2020\n\n\n\nSAN DIEGO, Feb. 11, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X™ cannabidiol (CBD) oil has been completed and published in the EC Neurology (ECNE), an internationally peer-reviewed journal that publishes articles related to worldwide research in neuroscience.\n\"We are encouraged by the study's results and look forward to understanding more about CBD's potential effects as we continue to conduct research on this topic,\" said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \"There are many people who are already using our products to experience a variety of health and wellness benefits. We believe that with the added assurance of these results, there will be many other people who may take interest in our products.\"\n\"For many children, there are countless pharmaceutical drugs that either don't work for them or produce a variety of harmful side effects,\" said Dr. Carlos G. Aguirre-Velázquez, a globally recognized pediatric neurologist and lead researcher on the study. \"We are optimistic that this study will be one of many that showcases the potential for hemp CBD oil to be safe and useful.\"\nThis is just one example of the Company's dedication to furthering innovative research within the cannabis industry. In 2019, Medical Marijuana, Inc. completed a one-year stability study in compliance with FDA/ICH guidelines on RSHO®-X and found that the product showed no change (less than 5%) in the CBD content, viscosity, package compatibility and complete m...